Analyst Ranking
Top 23%
#1114 out of 4867 analysts
Average Return
+17.56%
Win Rate
40%6 out of 15
Risk vs Reward
Poor
Good

Boris Peaker's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Argenx SeARGX
+376.50%$21.02$100.16
2017-06-11 -
2018-06-12
Buy
Aimmune Therapeutics IncAIMT
+122.09%$15.53$34.49
2020-07-12 -
2020-10-12
Buy
Cti Biopharma CorpCTIC
+106.59%$4.40$9.09
2023-04-16 -
2023-06-23
Buy
Cti Biopharma CorpCTIC
+28.03%$7.10$9.09
2022-07-06 -
2023-06-23
Buy
Lantheus Holdings IncLNTH
+15.94%$76.34$88.51
2023-12-03 -
2024-12-03
Buy

Boris Peaker Analyst Color

Get additional color on Boris Peaker's coverage of popular stocks

Boris Peaker's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Lantheus Holdings IncLNTH
1Buy$100.00N/AInitiates Coverage On
a year ago
Pacira Biosciences IncPCRX
1Buy$50.00N/AUpgrades
2 years ago
Cti Biopharma CorpCTIC
2Buy$8.00N/AMaintains
2 years ago
Seagen IncSGEN
1Hold$129.00N/AMaintains
2 years ago
Xencor IncXNCR
1BuyN/AN/AInitiates Coverage On
2 years ago
Macrogenics IncMGNX
1HoldN/AN/ADowngrades
2 years ago
Emergent Biosolutions IncEBS
1Hold$29.00N/AMaintains
3 years ago
Cytomx Therapeutics IncCTMX
1HoldN/AN/ADowngrades
3 years ago
Merck & Co IncMRK
1Hold$102.00N/AMaintains
3 years ago
Nektar TherapeuticsNKTR
1HoldN/AN/ADowngrades
3 years ago
Jounce Therapeutics IncJNCE
3BuyN/AN/AUpgrades
3 years ago
Tscan Therapeutics IncTCRX
1BuyN/AN/AInitiates Coverage On
4 years ago
Point Biopharma Global IncPNT
1BuyN/AN/AInitiates Coverage On
4 years ago
Celcuity IncCELC
1BuyN/AN/AInitiates Coverage On
4 years ago
Fusion Pharmaceuticals IncFUSN
1BuyN/AN/AInitiates Coverage On
5 years ago
Aimmune Therapeutics IncAIMT
1Buy$35.00N/AInitiates Coverage On
5 years ago
Sutro Biopharma IncSTRO
1BuyN/AN/AInitiates Coverage On
7 years ago
Mersana Therapeutics IncMRSN
1BuyN/AN/AInitiates Coverage On
8 years ago
Argenx SeARGX
1BuyN/AN/AInitiates Coverage On
8 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.